Objectives: The purposes of this study were to study
symptomatic metastatic cancer patients' knowledge and attitudes
toward end-of-life (EOL) care and to examine how patient-perceived
health status affects attitudes toward EOL care and survival.
Methods: From 1999 to 2002, 254 symptomatic metastatic
cancer patients at the VA New Jersey Health Care System completed the
Vermont Voices on Care of the Dying Questionnaire. Survival status and
location of death were obtained. Descriptive statistics and the chi
square method were used to assess the differences between African
Americans (N = 109) and Caucasians (N = 135), and
between different patient-perceived health status groups. A log-rank
test was performed to assess for differences in median survival length
between different patient-perceived health-status groups.
Results: Veterans' responses to the Vermont
questionnaire showed knowledge deficits regarding EOL care. There was
wide variation in self-rankings of health status: 45.6% of patients
rated their illness as serious and life threatening, 18.9% considered
their health problem significant but not life threatening, 2.8% thought
they were in good health, and one-third of patients were unsure about
their health status. Most patients (86.2%) preferred physician
frankness when communicating bad news and 61.8% preferred family
involvement in EOL discussions. African American patients were less
likely to have completed advance directives (p < 0.0001),
to have knowledge about hospice programs (p < 0.00001), and
to feel capable of assessing their health situation (p =
0.04). Patient-rated health status affected completion rates of advance
directives and survival.
Significance of the research: These findings demonstrate
knowledge deficits and racial differences in attitudes and values
toward EOL care in veterans with cancer. The Vermont questionnaire
enables patients to state their EOL preferences but may not be detailed
enough for clinical applications. Patient-rated health status may be an
important explanatory variable for EOL preferences and length of
survival.